Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mexico makes genomics R&D (research and development) a top priority:

This article was originally published in Clinica

Executive Summary

Mexico has pledged to put genomics at the top of its healthcare research modernisation agenda. At a recent symposium on the future of genomics in medicine, health minister Dr Julio Frenk Mora said that the current national healthcare research strategy sets out guarantees for funding in this area. He also announced that the establishment of the national genomics medicine institute is now subject only to the approval of congress. If approved, it will become the 11th national healthcare institute of the Mexican health service, the SSA.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT067745

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel